Stent Thrombosis Articles & Analysis
7 articles found
Background This paper outlines the first in-patient implantation of the EluNIR™ ridaforolimus eluting elastomeric stent (Medinol Ltd.). This complex case involved a patient with a flow-limiting lesion in a native coronary artery post bypass surgery. The new EluNIR stent system includes a stent with a low metal footprint which comprises struts of variable width: ultra-narrow struts having ...
ByMedinol
Background: This paper describes a challenging case of implantation of the EluNIR™ Ridaforolimus eluting elastomeric stent (Medinol Ltd.). This complex case involved a patient with a flow-limiting lesion in a native coronary artery post bypass surgery. The new EluNIR stent system includes a stent with a low metal footprint that comprises struts of variable width: ultra-narrow struts ...
ByMedinol
Incomplete stent expansion and malapposed stent struts are a predictor of subacute and late stent thrombosis. Appropriate lesion preparation prior to stent implantation is necessary to assure complete stent expansion and stent strut apposition. ...
Incomplete stent expansion and malapposed stent struts are a predictor of subacute and late stent thrombosis. Appropriate lesion preparation prior to stent implantation is necessary to assure complete stent expansion and stent strut apposition. ...
The new AV crossing devices and the use of direct fluoroscopic visualization instead of ultrasound are designed to avoid contrast injection and unnecessary manipulation in the tibial veins. Stent Graft Deployment The initial LimFlow System used a pin/pull stent graft delivery system for stent graft deployment. ...
TAILOR-PCI was a 7-year 5,300-patient clinical trial of precision medicine for cardiac stent patients, funded by Mayo Clinic and the National Institutes of Health (NIH). ...
Recapping TAILOR-PCI The TAILOR-PCI trial, funded by the Mayo Clinic and the National Institutes of Health (NIH), investigated whether rapid CYP2C19 genetic testing and personalized antiplatelet therapy could improve health outcomes for heart attack patients receiving cardiac stents. (1) This trial included 5,300 patients at 41 hospitals in the United States, Canada, Korea, and ...